CHORD THERAPEUTICS
Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. The company is advancing its lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG). The company was founded in 2014 and based in Geneva, Switzerland.
CHORD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.chordtherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
16 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS AWS Global Accelerator Webflow
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Tom Plitz Chief Executive Officer @ Chord Therapeutics
Chief Executive Officer
2020-08-01
Arthur Roach Founder and Head of Scientific Advisory Board @ Chord Therapeutics
Founder and Head of Scientific Advisory Board
2014-02-01
Founder
Investors List
Omega Funds
Omega Funds investment in Series A - Chord Therapeutics
Eclosion SA
Eclosion SA investment in Seed Round - Chord Therapeutics
Official Site Inspections
http://www.chordtherapeutics.com
Unable to get host informations!!!
More informations about "Chord Therapeutics"
Chord Therapeutics - Crunchbase Company Profile & Funding
Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. The company is advancing its lead drug …See details»
Chord Therapeutics Company Profile 2025: Valuation, Investors ...
Chord Therapeutics General Information Description. Operator of a pharmaceutical company intended to produce drugs to cure rare neurological diseases. The company is dedicated to …See details»
Chord Therapeutics SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Chord Therapeutics SA of Eysins, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Chord Therapeutics - Overview, News & Competitors - ZoomInfo
Chord Therapeutics contact info: Phone number: +41 794175474 Website: www.chordtherapeutics.com What does Chord Therapeutics do? Chord Therapeutics is a …See details»
Acquisition-of-Chord-Therapeutics - News | Merck
Dec 20, 2021 About Chord Therapeutics Chord Therapeutics is a Swiss-based clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. Chord is advancing its lead …See details»
Chord Therapeutics Company Profile: Overview and Full News …
Chord Therapeutics is a biotechnology company based in Geneve that specializes in developing innovative therapies for neurological disorders. The company operates in the commercial …See details»
Chord Therapeutics Company Profile - Office Locations ... - Craft
Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. The company aims to develop the first …See details»
Merck acquires Chord Therapeutics - 2021-12-20 - Crunchbase
Dec 20, 2021 Chord Therapeutics Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases. Acquiring Organization: Merck Merck is a …See details»
CHORD Therapeutics SÃ rl - startup.ch
CHORD Therapeutics Sà rl: CHORD Therapeutics is dedicated to repurposing the small molecule drug CRD1, under orphan drug/orphan medicinal product designation, to bring a new effective …See details»
Chord Therapeutics SA - Drug pipelines, Patents, Clinical trials
Explore Chord Therapeutics SA with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:Cladribine.See details»
Chord Therapeutics - VentureRadar
CHORD Therapeutics is dedicated to repurposing the small molecule drug CRD1, under orphan drug/orphan medicinal product designation, to bring a new effective therapy to patients with life …See details»
Chord Therapeutics - Company Profile - Tracxn
Nov 13, 2024 Chord Therapeutics is a developer of drugs for the treatment of rare neurological diseases. It aims to redevelop CRD1, to bring new therapies for severe, rare autoimmune …See details»
Merck Expands Neuroinflammatory Pipeline with Acquisition of …
About Chord Therapeutics Chord Therapeutics is a Swiss-based clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling …See details»
Chord Therapeutics - Products, Competitors, Financials, Employees ...
Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. It is advancing its lead drug candidate …See details»
Merck acquires Geneva-based biopharmaceutical company Chord …
Feb 2, 2022 Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck. Chord Therapeutics was …See details»
Merck acquires Chord Therapeutics - startupticker.ch
Dec 20, 2021 Chord Therapeutics was launched in October 2020 by leading healthcare venture capital firm Omega Funds, the sole investor in the Company’s USD 16 million Series A …See details»
Chord Therapeutics | EU-Startups
Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. We are advancing our lead drug …See details»
Chord Therapeutics Company Information - Funding, Investors, …
The company Chord Therapeutics has raised a total of $16m in funding over 1 rounds. Key Insights: Series A: $16m; 2020. Chord Therapeutics Series A (2020, $16M) $16m. Discover …See details»
Merck acquires Geneva-based biopharmaceutical company Chord …
Nov 29, 2024 Merck invests into Cadribine to try to cure rare neuroinflammatory diseases . Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing drugs for …See details»
Merck Acquires Chord Therapeutics to Expand Neuroinflammatory …
GENEVA, Dec. 20, 2021 /PRNewswire/ -- Chord Therapeutics (Chord), a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, today …See details»